EMEA-001143-PIP01-11-M04
Key facts
| Invented name |
|
| Active substance |
cabozantinib
|
| Therapeutic area |
Oncology
|
| Decision number |
P/0357/2022
|
| PIP number |
EMEA-001143-PIP01-11-M04
|
| Pharmaceutical form(s) |
|
| Condition(s) / indication(s) |
Treatment of solid malignant tumours
|
| Route(s) of administration |
Oral use
|
| Contact for public enquiries |
Ipsen Pharma
E-mail: GlobalMedInfo@ipsen.com |
| Decision type |
PM: decision on the application for modification of an agreed PIP
|